> top > docs > PMC:7289100 > spans > 30099-38201 > annotations

PMC:7289100 / 30099-38201 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T105 1104-1117 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T106 1134-1139 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T107 3054-3059 Body_part denotes bowel http://purl.org/sig/ont/fma/fma7199
T108 3840-3845 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T109 3894-3899 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T110 4582-4599 Body_part denotes connective tissue http://purl.org/sig/ont/fma/fma9640
T111 4970-4987 Body_part denotes connective tissue http://purl.org/sig/ont/fma/fma9640
T112 6661-6665 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T113 7026-7039 Body_part denotes interleukin-6 http://purl.org/sig/ont/fma/fma264829
T114 7696-7704 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T115 7766-7774 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T43 1104-1117 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T44 1134-1139 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T45 3840-3845 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T46 4582-4599 Body_part denotes connective tissue http://purl.obolibrary.org/obo/UBERON_0002384
T47 4593-4599 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T48 4970-4987 Body_part denotes connective tissue http://purl.obolibrary.org/obo/UBERON_0002384
T49 4981-4987 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T50 6356-6362 Body_part denotes vessel http://purl.obolibrary.org/obo/UBERON_0000055
T51 6661-6665 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T378 26-44 Disease denotes rheumatic diseases http://purl.obolibrary.org/obo/MONDO_0005554
T379 49-57 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T380 58-67 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T381 216-234 Disease denotes rheumatic diseases http://purl.obolibrary.org/obo/MONDO_0005554
T382 403-416 Disease denotes viral disease http://purl.obolibrary.org/obo/MONDO_0005108
T383 536-552 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T384 612-630 Disease denotes rheumatic diseases http://purl.obolibrary.org/obo/MONDO_0005554
T385 713-722 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T386 898-915 Disease denotes rheumatic disease http://purl.obolibrary.org/obo/MONDO_0005554
T387 939-942 Disease denotes SLE http://purl.obolibrary.org/obo/MONDO_0007915
T388 1074-1084 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T389 1237-1240 Disease denotes SLE http://purl.obolibrary.org/obo/MONDO_0007915
T390 1456-1461 Disease denotes lupus http://purl.obolibrary.org/obo/MONDO_0004670
T391 1551-1564 Disease denotes tenosynovitis http://purl.obolibrary.org/obo/MONDO_0004855
T392 1622-1630 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T393 1707-1725 Disease denotes rheumatic diseases http://purl.obolibrary.org/obo/MONDO_0005554
T394 1755-1763 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T395 1810-1815 Disease denotes lupus http://purl.obolibrary.org/obo/MONDO_0004670
T396 1858-1863 Disease denotes lupus http://purl.obolibrary.org/obo/MONDO_0004670
T397 1893-1901 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T398 1954-1974 Disease denotes rheumatoid arthritis http://purl.obolibrary.org/obo/MONDO_0008383
T399 1965-1974 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578
T400 2000-2017 Disease denotes rheumatic disease http://purl.obolibrary.org/obo/MONDO_0005554
T401 2094-2097 Disease denotes SLE http://purl.obolibrary.org/obo/MONDO_0007915
T402 2143-2152 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T403 2222-2237 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T404 2228-2237 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T405 2394-2417 Disease denotes end-stage renal disease http://purl.obolibrary.org/obo/MONDO_0004375
T406 2404-2417 Disease denotes renal disease http://purl.obolibrary.org/obo/MONDO_0002118|http://purl.obolibrary.org/obo/MONDO_0005240
T408 2464-2499 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T409 2470-2499 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T410 2676-2693 Disease denotes rheumatic disease http://purl.obolibrary.org/obo/MONDO_0005554
T411 2891-2911 Disease denotes inflammatory disease http://purl.obolibrary.org/obo/MONDO_0021166
T412 2960-2980 Disease denotes rheumatoid arthritis http://purl.obolibrary.org/obo/MONDO_0008383
T413 2971-2980 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578
T414 2982-3001 Disease denotes psoriatic arthritis http://purl.obolibrary.org/obo/MONDO_0011849
T415 2992-3001 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578
T416 3003-3025 Disease denotes ankylosing spondylitis http://purl.obolibrary.org/obo/MONDO_0005306
T417 3014-3025 Disease denotes spondylitis http://purl.obolibrary.org/obo/MONDO_0003937
T418 3027-3036 Disease denotes psoriasis http://purl.obolibrary.org/obo/MONDO_0005083
T419 3041-3067 Disease denotes inflammatory bowel disease http://purl.obolibrary.org/obo/MONDO_0005265
T420 3707-3724 Disease denotes rheumatic disease http://purl.obolibrary.org/obo/MONDO_0005554
T421 3767-3787 Disease denotes rheumatoid arthritis http://purl.obolibrary.org/obo/MONDO_0008383
T422 3778-3787 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578
T423 3801-3819 Disease denotes systemic sclerosis http://purl.obolibrary.org/obo/MONDO_0005100
T424 4006-4023 Disease denotes rheumatic disease http://purl.obolibrary.org/obo/MONDO_0005554
T425 4309-4329 Disease denotes rheumatoid arthritis http://purl.obolibrary.org/obo/MONDO_0008383
T426 4320-4329 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578
T427 4582-4607 Disease denotes connective tissue disease http://purl.obolibrary.org/obo/MONDO_0003900|http://purl.obolibrary.org/obo/MONDO_0005554
T429 4700-4709 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T430 4751-4768 Disease denotes rheumatic disease http://purl.obolibrary.org/obo/MONDO_0005554
T431 4885-4913 Disease denotes systemic lupus erythematosus http://purl.obolibrary.org/obo/MONDO_0007915
T432 4894-4913 Disease denotes lupus erythematosus http://purl.obolibrary.org/obo/MONDO_0004670
T433 4924-4942 Disease denotes systemic sclerosis http://purl.obolibrary.org/obo/MONDO_0005100
T434 4953-4995 Disease denotes undifferentiated connective tissue disease http://purl.obolibrary.org/obo/MONDO_0019527
T435 4970-4995 Disease denotes connective tissue disease http://purl.obolibrary.org/obo/MONDO_0003900|http://purl.obolibrary.org/obo/MONDO_0005554
T437 5008-5024 Disease denotes Sjogren syndrome http://purl.obolibrary.org/obo/MONDO_0010030
T438 5264-5282 Disease denotes systemic sclerosis http://purl.obolibrary.org/obo/MONDO_0005100
T439 5371-5380 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T440 5529-5544 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T441 5535-5544 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T442 5935-5953 Disease denotes rheumatic diseases http://purl.obolibrary.org/obo/MONDO_0005554
T443 6124-6132 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T444 6188-6197 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T445 6363-6373 Disease denotes vasculitis http://purl.obolibrary.org/obo/MONDO_0018882
T446 6378-6410 Disease denotes granulomatosis with polyangiitis http://purl.obolibrary.org/obo/MONDO_0012105
T447 6436-6445 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T448 6610-6628 Disease denotes systemic sclerosis http://purl.obolibrary.org/obo/MONDO_0005100
T449 6648-6673 Disease denotes interstitial lung disease http://purl.obolibrary.org/obo/MONDO_0015925
T450 6661-6673 Disease denotes lung disease http://purl.obolibrary.org/obo/MONDO_0005275
T451 6675-6678 Disease denotes ILD http://purl.obolibrary.org/obo/MONDO_0015925
T452 6734-6743 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T453 6802-6820 Disease denotes systemic sclerosis http://purl.obolibrary.org/obo/MONDO_0005100
T454 6938-6949 Disease denotes scleroderma http://purl.obolibrary.org/obo/MONDO_0019340
T455 6961-6964 Disease denotes ILD http://purl.obolibrary.org/obo/MONDO_0015925
T456 6969-6982 Disease denotes polyarthritis http://purl.obolibrary.org/obo/MONDO_0024280
T457 7364-7377 Disease denotes acute disease http://purl.obolibrary.org/obo/MONDO_0020683
T458 7553-7557 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T459 7918-7937 Disease denotes autoimmune diseases http://purl.obolibrary.org/obo/MONDO_0007179
T460 7969-7978 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T238 271-276 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T239 953-954 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T240 1104-1117 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T241 1134-1139 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T242 1222-1223 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T243 1295-1296 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T244 1381-1386 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T245 1534-1535 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T246 1571-1572 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T247 1984-1985 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T248 2049-2050 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T249 2164-2165 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T250 2776-2777 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T251 2847-2848 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T252 3098-3100 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T253 3840-3845 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T254 3894-3899 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T255 4250-4251 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T256 4582-4599 http://purl.obolibrary.org/obo/UBERON_0002384 denotes connective tissue
T257 4582-4599 http://www.ebi.ac.uk/efo/EFO_0000952 denotes connective tissue
T258 4810-4812 http://purl.obolibrary.org/obo/CLO_0001527 denotes 94
T259 4871-4878 http://purl.obolibrary.org/obo/UBERON_0003100 denotes females
T260 4970-4987 http://purl.obolibrary.org/obo/UBERON_0002384 denotes connective tissue
T261 4970-4987 http://www.ebi.ac.uk/efo/EFO_0000952 denotes connective tissue
T262 5105-5106 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T263 5244-5250 http://purl.obolibrary.org/obo/UBERON_0003100 denotes female
T264 5335-5336 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T265 5454-5455 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T266 5527-5528 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T267 5572-5573 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T268 5579-5583 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T269 5595-5596 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T270 5871-5872 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T271 6217-6218 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T272 6313-6316 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T273 6356-6362 http://purl.obolibrary.org/obo/UBERON_0000055 denotes vessel
T274 6661-6665 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T275 6661-6665 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T276 6919-6920 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T277 7026-7039 http://purl.obolibrary.org/obo/PR_000001393 denotes interleukin-6
T278 7076-7077 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T279 7216-7217 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T280 7277-7282 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T281 7286-7287 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T282 7392-7393 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T283 7826-7839 http://purl.obolibrary.org/obo/OBI_0000245 denotes organizations
T284 7958-7959 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T128 853-858 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T129 1006-1011 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T130 1212-1217 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T131 2849-2854 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T132 3222-3227 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T133 3430-3435 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T134 3506-3511 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T135 3934-3950 Chemical denotes antiviral agents http://purl.obolibrary.org/obo/CHEBI_22587
T136 3952-3963 Chemical denotes antibiotics http://purl.obolibrary.org/obo/CHEBI_33281
T137 5145-5160 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T138 5441-5452 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T139 6077-6086 Chemical denotes rituximab http://purl.obolibrary.org/obo/CHEBI_64357
T140 6090-6101 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T141 7181-7192 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T142 7454-7465 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T143 7608-7610 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T145 7741-7743 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T180 939-942 Phenotype denotes SLE http://purl.obolibrary.org/obo/HP_0002725
T181 1067-1084 Phenotype denotes severe infections http://purl.obolibrary.org/obo/HP_0032169
T182 1237-1240 Phenotype denotes SLE http://purl.obolibrary.org/obo/HP_0002725
T183 1954-1974 Phenotype denotes rheumatoid arthritis http://purl.obolibrary.org/obo/HP_0001370
T184 2094-2097 Phenotype denotes SLE http://purl.obolibrary.org/obo/HP_0002725
T185 2394-2417 Phenotype denotes end-stage renal disease http://purl.obolibrary.org/obo/HP_0003774
T186 2470-2490 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T187 2960-2980 Phenotype denotes rheumatoid arthritis http://purl.obolibrary.org/obo/HP_0001370
T188 2992-3001 Phenotype denotes arthritis http://purl.obolibrary.org/obo/HP_0001369
T189 3027-3036 Phenotype denotes psoriasis http://purl.obolibrary.org/obo/HP_0003765
T190 3041-3067 Phenotype denotes inflammatory bowel disease http://purl.obolibrary.org/obo/HP_0002037
T191 3767-3787 Phenotype denotes rheumatoid arthritis http://purl.obolibrary.org/obo/HP_0001370
T192 4309-4329 Phenotype denotes rheumatoid arthritis http://purl.obolibrary.org/obo/HP_0001370
T193 4885-4913 Phenotype denotes systemic lupus erythematosus http://purl.obolibrary.org/obo/HP_0002725
T194 5371-5380 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T195 6188-6197 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T196 6350-6373 Phenotype denotes large-vessel vasculitis http://purl.obolibrary.org/obo/HP_0005310
T197 6378-6392 Phenotype denotes granulomatosis http://purl.obolibrary.org/obo/HP_0002955
T198 6648-6673 Phenotype denotes interstitial lung disease http://purl.obolibrary.org/obo/HP_0006530
T199 6675-6678 Phenotype denotes ILD http://purl.obolibrary.org/obo/HP_0006530
T200 6734-6743 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T201 6938-6949 Phenotype denotes scleroderma http://purl.obolibrary.org/obo/HP_0100324
T202 6961-6964 Phenotype denotes ILD http://purl.obolibrary.org/obo/HP_0006530
T203 7696-7710 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T204 7918-7937 Phenotype denotes autoimmune diseases http://purl.obolibrary.org/obo/HP_0002960

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T14 536-552 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections
T15 2222-2237 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T16 5529-5544 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T191 0-67 Sentence denotes 8 Preexisting autoimmune rheumatic diseases and COVID-19 infection
T192 68-424 Sentence denotes Since the breakout of the Covid-19 in late 2019 in China, many unresolved issues regarding both dealing with the fate of the preexisting autoimmune rheumatic diseases in patients who are affected by the virus including those under immunosuppressive and biologic therapy, as well as the impact of these therapies on the severity of the viral disease itself.
T193 425-745 Sentence denotes Early reports in the course of the pandemia suggested that based on the data recovered from other and previous viral infections, there would be an increased probability for patients with rheumatic diseases to acquire the Covid-19 disease or are they prone to an increased severity of the infection if they do acquire it.
T194 746-924 Sentence denotes On the contrary, however, early on, there was some evidence regarding the potential benefit of some of the drugs which have been used in the therapy of rheumatic disease [83,84].
T195 925-1000 Sentence denotes Patients with SLE had posed a serious concern during the Covid-19 pandemia.
T196 1001-1218 Sentence denotes This group of patients is well known to bear an increased risk of severe infections, due to both their immune system and the related organ damage as well as due to the therapies used including immunosuppressive drugs.
T197 1219-1570 Sentence denotes In a report of 19 SLE patients from France who were clinically quiescent on a long-term treatment with Hydroxychloroquine (HCQ) and were infected by the Covid-19 virus, the authors were able to conclude that the clinical course of these lupus patients did not show any signs of the disease exacerbation, except for a single case of tenosynovitis [85].
T198 1571-1821 Sentence denotes A preliminary analysis of patients included in the COVID-19 Global Rheumatology Alliance registry, showed that 17% of 110 patients with rheumatic diseases who have been diagnosed with COVID-19 as of April the 1st, 2020- were patients with lupus [86].
T199 1822-2045 Sentence denotes Thus the frequency of patients with lupus who have been diagnosed with COVID-19 was over-represented, at about twice as compared to rheumatoid arthritis which is a much commoner rheumatic disease among the adult population.
T200 2046-2505 Sentence denotes In a recent small report from northern Italy of SLE patients with either swab confirmed Covid-19 infection (n = 4) or a clinical diagnosis, based on 3 out of 4 symptoms of the viral infection (n = 8), the authors stated that the disease course was generally mild and self-resolving although one of the four patients who was on haemodialysis due to end-stage renal disease, needed intensive care for the development of acute respiratory distress syndrome [87].
T201 2506-2772 Sentence denotes Based on the clinical information published to date from the new and previous outbreaks caused by the coronaviruses, there is no overwhelming evidence that patients with rheumatic disease are at an increased risk compared with other comorbidities [[88], [89], [90]].
T202 2773-3150 Sentence denotes In a rather larger prospective report from New York, the authors reviewed a group of 86 patients with immune-mediated inflammatory disease including 59 cases of inflammatory arthritides (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis and inflammatory bowel disease) with confirmed Covid-19, and 27 additional patients with suspected Covid-19 [91].
T203 3151-3228 Sentence denotes Two-thirds of the patients were on biologics or other immunomodulatory drugs.
T204 3229-3363 Sentence denotes Hospitalized patients, as compared to those who were only followed on an out-patient basis, had more classical Covid-19 comorbidities.
T205 3364-3524 Sentence denotes Conventional DMARDs were used more frequently in the hospitalized group of patients, whereas biologics were more often used in the ambulatory group of patients.
T206 3525-3652 Sentence denotes The authors suggest that based on their findings the baseline use of biologics was not associated with worse Covid-19 outcomes.
T207 3653-3757 Sentence denotes In another small report from China five patients with rheumatic disease and Covid-19 are described [92].
T208 3758-3820 Sentence denotes Four had rheumatoid arthritis and one with systemic sclerosis.
T209 3821-3900 Sentence denotes All 5 patients had chest CT showing patchy ground glass opacities in the lungs.
T210 3901-4024 Sentence denotes All 5 patients were treated with antiviral agents, antibiotics and the immunomodulatory agents for their rheumatic disease.
T211 4025-4238 Sentence denotes Two of the 5 patients remained in stable condition in the course of the hospitalization, 2 progressed to severe Covid-19 and one was critically ill, though all patients recovered and were discharged from hospital.
T212 4239-4512 Sentence denotes Similarly, a report by Monti et al. [93] suggested that patients with rheumatoid arthritis treated with biological DMARDs or targeted synthetic DMARDs did not seem to be at increased risk of life-threatening complications from Covid-19 compared with the general population.
T213 4513-4814 Sentence denotes Another recent study from Italy supports the approach of encouraging connective tissue disease patients to maintain the ongoing rheumatologic therapy as well as adhere to the measures of infection prevention, thus avoiding relapse of the rheumatic disease without increasing the risk of Covid-19 [94].
T214 4815-5034 Sentence denotes Their study population included 123 adult patients (110 females) with systemic lupus erythematosus (n = 61), systemic sclerosis (n = 43), undifferentiated connective tissue disease (n = 9) and Sjogren syndrome (n = 10).
T215 5035-5169 Sentence denotes About 60% of the patients were treated with conventional DMARDs, with a similar percentage of patients taking corticosteroids as well.
T216 5170-5221 Sentence denotes Twenty five of the 110 patients received biologics.
T217 5222-5453 Sentence denotes Only one rather young female patient with systemic sclerosis was found to be positive for Covid-19 and developed a critical course with interstitial pneumonia leading to her death despite intubation and an attempt with tocilizumab.
T218 5454-5630 Sentence denotes A further 14 patients reported mild respiratory symptoms compatible with a viral infection but did not have access to a swab test and showed a rapid recovery of their symptoms.
T219 5631-5822 Sentence denotes The authors concluded that only 5 out of their 123 patients had discontinued their current rheumatological therapy, with none of the rest 115 patients experiencing flare-ups of their disease.
T220 5823-6032 Sentence denotes Similarly, Conticini et al recently reported of a large cohort of 859 patients from Italy affected by different rheumatic diseases, which were treated by biological DMARDs or by targeted synthetic DMARDs [95].
T221 6033-6198 Sentence denotes Only 2 patients who were both on biologics (rituximab or tocilizumab), were diagnosed with COVID-19, one of which even with bilateral diffuse interstitial pneumonia.
T222 6199-6286 Sentence denotes Both patients had a complete recovery without interruption of the biological treatment.
T223 6287-6454 Sentence denotes Similar favorable outcome has been reported for few cases with large-vessel vasculitis and granulomatosis with polyangiitis associated with Covid-19 infection [96,97].
T224 6455-6547 Sentence denotes Thus it seems that baseline use of biologics is not associated with worse Covid-19 outcomes.
T225 6548-6764 Sentence denotes The situation might be different with patients suffering from systemic sclerosis, where the typical interstitial lung disease (ILD) could share some CT features with Covid-19 associated pneumonia [[98], [99], [100]].
T226 6765-6913 Sentence denotes Currently the impact of pre-existing systemic sclerosis associated with pulmonary and cardiac involvement, on the course of Covid-19 is yet unknown.
T227 6914-7126 Sentence denotes Such a single case with scleroderma associated ILD and polyarthritis, who had been previously treated with anti-interleukin-6 receptor blocker (Tocilizumab) with a favorable response, was recently reported [101].
T228 7127-7308 Sentence denotes In the course of this therapy, 4 weeks after the last tocilizumab infusion, she reported a contact with Covid-19 and was found to be positive for the virus by a nasopharyngeal swab.
T229 7309-7476 Sentence denotes Her condition remained stable during the course of the acute disease and following a negative swab and cure, she had received the next scheduled tocilizumab injection.
T230 7477-7711 Sentence denotes It should be noted that early reports from China during the outbreak of the SARS-Cov2 were able to demonstrate increased levels of IL-6 and CRP, suggesting that this subgroup of patients may develop the Covid19 related cytokine storm.
T231 7712-7797 Sentence denotes Randomized trials using anti-IL-6 receptor monoclonal antibody are currently ongoing.
T232 7798-7979 Sentence denotes Recently many countries and organizations have set up registries incorporating patients with pre-existing rheumatic and autoimmune diseases who had encountered a Covid-19 infection.
T233 7980-8102 Sentence denotes The largest international registries include The Global Rheumatology Alliance of Covid-19 and the Eular Covid-19 database.

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T422 15-25 UBERON:0002405 denotes autoimmune
T423 49-57 SP_7 denotes COVID-19
T424 94-102 SP_7 denotes Covid-19
T425 205-215 UBERON:0002405 denotes autoimmune
T426 271-276 NCBITaxon:10239 denotes virus
T427 299-316 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T428 403-408 NCBITaxon:10239 denotes viral
T429 536-541 NCBITaxon:10239 denotes viral
T430 646-654 SP_7 denotes Covid-19
T431 853-858 CHEBI:23888;CHEBI:23888 denotes drugs
T432 982-990 SP_7 denotes Covid-19
T433 1104-1117 UBERON:0002405 denotes immune system
T434 1134-1139 UBERON:0000062 denotes organ
T435 1194-1211 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T436 1212-1217 CHEBI:23888;CHEBI:23888 denotes drugs
T437 1282-1291 GO:0044838 denotes quiescent
T438 1322-1340 CHEBI:5801;DG_20;CHEBI:5801 denotes Hydroxychloroquine
T439 1372-1380 SP_7 denotes Covid-19
T440 1381-1386 NCBITaxon:10239 denotes virus
T441 1622-1630 SP_7 denotes COVID-19
T442 1755-1763 SP_7 denotes COVID-19
T443 1893-1901 SP_7 denotes COVID-19
T444 2028-2033 UBERON:0007023 denotes adult
T445 2134-2142 SP_7 denotes Covid-19
T446 2222-2227 NCBITaxon:10239 denotes viral
T447 2404-2409 UBERON:0002113 denotes renal
T448 2470-2481 UBERON:0001004 denotes respiratory
T449 2608-2621 NCBITaxon:11118 denotes coronaviruses
T450 2875-2881 UBERON:0002405 denotes immune
T451 3041-3059 UBERON:0000160 denotes inflammatory bowel
T452 3084-3092 SP_7 denotes Covid-19
T453 3136-3144 SP_7 denotes Covid-19
T454 3205-3221 CHEBI:35705;CHEBI:35705 denotes immunomodulatory
T455 3222-3227 CHEBI:23888;CHEBI:23888 denotes drugs
T456 3340-3348 SP_7 denotes Covid-19
T457 3495-3505 GO:0040011 denotes ambulatory
T458 3634-3642 SP_7 denotes Covid-19
T459 3729-3737 SP_7 denotes Covid-19
T460 3840-3845 UBERON:0001443 denotes chest
T461 3894-3899 UBERON:0000170 denotes lungs
T462 3934-3950 CHEBI:22587;CHEBI:22587 denotes antiviral agents
T463 3952-3963 CHEBI:33282;CHEBI:33282 denotes antibiotics
T464 4137-4145 SP_7 denotes Covid-19
T465 4430-4434 UBERON:0000104 denotes life
T466 4466-4474 SP_7 denotes Covid-19
T467 4582-4599 UBERON:0002384 denotes connective tissue
T468 4800-4808 SP_7 denotes Covid-19
T469 4851-4856 UBERON:0007023 denotes adult
T470 4970-4987 UBERON:0002384 denotes connective tissue
T471 5145-5160 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T472 5312-5320 SP_7 denotes Covid-19
T473 5358-5370 UBERON:0005169 denotes interstitial
T474 5396-5401 GO:0016265 denotes death
T475 5441-5452 DG_35 denotes tocilizumab
T476 5490-5501 UBERON:0001004 denotes respiratory
T477 5529-5534 NCBITaxon:10239 denotes viral
T478 6090-6101 DG_35 denotes tocilizumab
T479 6124-6132 SP_7 denotes COVID-19
T480 6175-6187 UBERON:0005169 denotes interstitial
T481 6356-6362 UBERON:0000055 denotes vessel
T482 6427-6435 SP_7 denotes Covid-19
T483 6529-6537 SP_7 denotes Covid-19
T484 6648-6660 UBERON:0005169 denotes interstitial
T485 6661-6665 UBERON:0002048 denotes lung
T486 6714-6722 SP_7 denotes Covid-19
T487 6837-6846 UBERON:0002048 denotes pulmonary
T488 6851-6858 UBERON:0000948 denotes cardiac
T489 6889-6897 SP_7 denotes Covid-19
T490 7026-7039 PR:000001393 denotes interleukin-6
T491 7058-7069 DG_35 denotes Tocilizumab
T492 7181-7192 DG_35 denotes tocilizumab
T493 7231-7239 SP_7 denotes Covid-19
T494 7277-7282 NCBITaxon:10239 denotes virus
T495 7288-7302 UBERON:0001728 denotes nasopharyngeal
T496 7454-7465 DG_35 denotes tocilizumab
T497 7553-7562 SP_7 denotes SARS-Cov2
T498 7608-7612 PR:000001393 denotes IL-6
T499 7680-7687 SP_7 denotes Covid19
T500 7741-7745 PR:000001393 denotes IL-6
T501 7766-7774 GO:0042571 denotes antibody
T502 7918-7928 UBERON:0002405 denotes autoimmune
T503 7960-7968 SP_7 denotes Covid-19
T504 8061-8069 SP_7 denotes Covid-19
T505 8084-8092 SP_7 denotes Covid-19
T67815 15-25 UBERON:0002405 denotes autoimmune
T94261 49-57 SP_7 denotes COVID-19
T70814 94-102 SP_7 denotes Covid-19
T14206 205-215 UBERON:0002405 denotes autoimmune
T1510 271-276 NCBITaxon:10239 denotes virus
T87559 299-316 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T60635 403-408 NCBITaxon:10239 denotes viral
T2065 536-541 NCBITaxon:10239 denotes viral
T25480 646-654 SP_7 denotes Covid-19
T82970 853-858 CHEBI:23888;CHEBI:23888 denotes drugs
T848 982-990 SP_7 denotes Covid-19
T48434 1104-1117 UBERON:0002405 denotes immune system
T57744 1134-1139 UBERON:0000062 denotes organ
T20754 1194-1211 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T36897 1212-1217 CHEBI:23888;CHEBI:23888 denotes drugs
T93117 1282-1291 GO:0044838 denotes quiescent
T45177 1322-1340 CHEBI:5801;DG_20;CHEBI:5801 denotes Hydroxychloroquine
T67338 1372-1380 SP_7 denotes Covid-19
T28381 1381-1386 NCBITaxon:10239 denotes virus
T79311 1622-1630 SP_7 denotes COVID-19
T26923 1755-1763 SP_7 denotes COVID-19
T22974 1893-1901 SP_7 denotes COVID-19
T3514 2028-2033 UBERON:0007023 denotes adult
T1056 2134-2142 SP_7 denotes Covid-19
T19195 2222-2227 NCBITaxon:10239 denotes viral
T29423 2404-2409 UBERON:0002113 denotes renal
T93140 2470-2481 UBERON:0001004 denotes respiratory
T35890 2608-2621 NCBITaxon:11118 denotes coronaviruses
T73009 2875-2881 UBERON:0002405 denotes immune
T96076 3041-3059 UBERON:0000160 denotes inflammatory bowel
T43599 3084-3092 SP_7 denotes Covid-19
T64476 3136-3144 SP_7 denotes Covid-19
T42270 3205-3221 CHEBI:35705;CHEBI:35705 denotes immunomodulatory
T34744 3222-3227 CHEBI:23888;CHEBI:23888 denotes drugs
T12090 3340-3348 SP_7 denotes Covid-19
T59595 3495-3505 GO:0040011 denotes ambulatory
T84418 3634-3642 SP_7 denotes Covid-19
T45430 3729-3737 SP_7 denotes Covid-19
T51324 3840-3845 UBERON:0001443 denotes chest
T62297 3894-3899 UBERON:0000170 denotes lungs
T33738 3934-3950 CHEBI:22587;CHEBI:22587 denotes antiviral agents
T66845 3952-3963 CHEBI:33282;CHEBI:33282 denotes antibiotics
T46583 4137-4145 SP_7 denotes Covid-19
T18343 4430-4434 UBERON:0000104 denotes life
T20545 4466-4474 SP_7 denotes Covid-19
T41868 4582-4599 UBERON:0002384 denotes connective tissue
T17556 4800-4808 SP_7 denotes Covid-19
T37618 4851-4856 UBERON:0007023 denotes adult
T25019 4970-4987 UBERON:0002384 denotes connective tissue
T19419 5145-5160 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T66532 5312-5320 SP_7 denotes Covid-19
T36067 5358-5370 UBERON:0005169 denotes interstitial
T49106 5396-5401 GO:0016265 denotes death
T46616 5441-5452 DG_35 denotes tocilizumab
T85742 5490-5501 UBERON:0001004 denotes respiratory
T13050 5529-5534 NCBITaxon:10239 denotes viral
T83995 6090-6101 DG_35 denotes tocilizumab
T99552 6124-6132 SP_7 denotes COVID-19
T95971 6175-6187 UBERON:0005169 denotes interstitial
T71752 6356-6362 UBERON:0000055 denotes vessel
T6802 6427-6435 SP_7 denotes Covid-19
T77426 6529-6537 SP_7 denotes Covid-19
T77304 6648-6660 UBERON:0005169 denotes interstitial
T76641 6661-6665 UBERON:0002048 denotes lung
T15000 6714-6722 SP_7 denotes Covid-19
T82223 6837-6846 UBERON:0002048 denotes pulmonary
T59648 6851-6858 UBERON:0000948 denotes cardiac
T14806 6889-6897 SP_7 denotes Covid-19
T10790 7026-7039 PR:000001393 denotes interleukin-6
T98744 7058-7069 DG_35 denotes Tocilizumab
T10818 7181-7192 DG_35 denotes tocilizumab
T52732 7231-7239 SP_7 denotes Covid-19
T62313 7277-7282 NCBITaxon:10239 denotes virus
T34080 7288-7302 UBERON:0001728 denotes nasopharyngeal
T52079 7454-7465 DG_35 denotes tocilizumab
T92642 7553-7562 SP_7 denotes SARS-Cov2
T18190 7608-7612 PR:000001393 denotes IL-6
T44717 7680-7687 SP_7 denotes Covid19
T61028 7741-7745 PR:000001393 denotes IL-6
T59222 7766-7774 GO:0042571 denotes antibody
T19494 7918-7928 UBERON:0002405 denotes autoimmune
T95414 7960-7968 SP_7 denotes Covid-19
T23446 8061-8069 SP_7 denotes Covid-19
T9228 8084-8092 SP_7 denotes Covid-19

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
997 15-44 Disease denotes autoimmune rheumatic diseases MESH:D012216
998 49-57 Disease denotes COVID-19 MESH:C000657245
999 58-67 Disease denotes infection MESH:D007239
1010 238-246 Species denotes patients Tax:9606
1011 598-606 Species denotes patients Tax:9606
1012 94-102 Disease denotes Covid-19 MESH:C000657245
1013 216-234 Disease denotes rheumatic diseases MESH:D012216
1014 403-416 Disease denotes viral disease MESH:D001102
1015 536-552 Disease denotes viral infections MESH:D001102
1016 612-630 Disease denotes rheumatic diseases MESH:D012216
1017 646-654 Disease denotes Covid-19 MESH:C000657245
1018 713-722 Disease denotes infection MESH:D007239
1019 898-915 Disease denotes rheumatic disease MESH:D012216
1151 7608-7612 Gene denotes IL-6 Gene:3569
1152 7617-7620 Gene denotes CRP Gene:1401
1153 925-933 Species denotes Patients Tax:9606
1154 1015-1023 Species denotes patients Tax:9606
1155 1241-1249 Species denotes patients Tax:9606
1156 1372-1386 Species denotes Covid-19 virus Tax:2697049
1157 1462-1470 Species denotes patients Tax:9606
1158 1597-1605 Species denotes patients Tax:9606
1159 1693-1701 Species denotes patients Tax:9606
1160 1796-1804 Species denotes patients Tax:9606
1161 1844-1852 Species denotes patients Tax:9606
1162 2098-2106 Species denotes patients Tax:9606
1163 2353-2361 Species denotes patients Tax:9606
1164 2608-2621 Species denotes coronaviruses Tax:11118
1165 2662-2670 Species denotes patients Tax:9606
1166 2861-2869 Species denotes patients Tax:9606
1167 3112-3120 Species denotes patients Tax:9606
1168 3169-3177 Species denotes patients Tax:9606
1169 3242-3250 Species denotes patients Tax:9606
1170 3306-3313 Species denotes patient Tax:9606
1171 3439-3447 Species denotes patients Tax:9606
1172 3515-3523 Species denotes patients Tax:9606
1173 3693-3701 Species denotes patients Tax:9606
1174 3827-3835 Species denotes patients Tax:9606
1175 3907-3915 Species denotes patients Tax:9606
1176 4038-4046 Species denotes patients Tax:9606
1177 4185-4193 Species denotes patients Tax:9606
1178 4295-4303 Species denotes patients Tax:9606
1179 4608-4616 Species denotes patients Tax:9606
1180 4857-4865 Species denotes patients Tax:9606
1181 5052-5060 Species denotes patients Tax:9606
1182 5129-5137 Species denotes patients Tax:9606
1183 5193-5201 Species denotes patients Tax:9606
1184 5251-5258 Species denotes patient Tax:9606
1185 5467-5475 Species denotes patients Tax:9606
1186 5682-5690 Species denotes patients Tax:9606
1187 5773-5781 Species denotes patients Tax:9606
1188 5893-5901 Species denotes patients Tax:9606
1189 6040-6048 Species denotes patients Tax:9606
1190 6204-6212 Species denotes patients Tax:9606
1191 6586-6594 Species denotes patients Tax:9606
1192 7553-7562 Species denotes SARS-Cov2 Tax:2697049
1193 7655-7663 Species denotes patients Tax:9606
1194 7877-7885 Species denotes patients Tax:9606
1195 1322-1340 Chemical denotes Hydroxychloroquine MESH:D006886
1196 1342-1345 Chemical denotes HCQ MESH:D006886
1197 5441-5452 Chemical denotes tocilizumab MESH:C502936
1198 6077-6086 Chemical denotes rituximab MESH:D000069283
1199 6090-6101 Chemical denotes tocilizumab MESH:C502936
1200 7058-7069 Chemical denotes Tocilizumab MESH:C502936
1201 7181-7192 Chemical denotes tocilizumab MESH:C502936
1202 7454-7465 Chemical denotes tocilizumab MESH:C502936
1203 939-942 Disease denotes SLE MESH:D008180
1204 982-990 Disease denotes Covid-19 MESH:C000657245
1205 1074-1084 Disease denotes infections MESH:D007239
1206 1237-1240 Disease denotes SLE MESH:D008180
1207 1356-1364 Disease denotes infected MESH:D007239
1208 1456-1461 Disease denotes lupus MESH:D008180
1209 1551-1564 Disease denotes tenosynovitis MESH:D013717
1210 1622-1630 Disease denotes COVID-19 MESH:C000657245
1211 1707-1725 Disease denotes rheumatic diseases MESH:D012216
1212 1755-1763 Disease denotes COVID-19 MESH:C000657245
1213 1810-1815 Disease denotes lupus MESH:D008180
1214 1858-1863 Disease denotes lupus MESH:D008180
1215 1893-1901 Disease denotes COVID-19 MESH:C000657245
1216 1954-1974 Disease denotes rheumatoid arthritis MESH:D001172
1217 2000-2017 Disease denotes rheumatic disease MESH:D012216
1218 2094-2097 Disease denotes SLE MESH:D008180
1219 2134-2142 Disease denotes Covid-19 MESH:C000657245
1220 2143-2152 Disease denotes infection MESH:D007239
1221 2222-2237 Disease denotes viral infection MESH:D001102
1222 2404-2417 Disease denotes renal disease MESH:D007674
1223 2464-2499 Disease denotes acute respiratory distress syndrome MESH:D012128
1224 2676-2693 Disease denotes rheumatic disease MESH:D012216
1225 2960-2980 Disease denotes rheumatoid arthritis MESH:D001172
1226 2982-3001 Disease denotes psoriatic arthritis MESH:D015535
1227 3003-3025 Disease denotes ankylosing spondylitis MESH:D013167
1228 3027-3036 Disease denotes psoriasis MESH:D011565
1229 3041-3067 Disease denotes inflammatory bowel disease MESH:D015212
1230 3084-3092 Disease denotes Covid-19 MESH:C000657245
1231 3136-3144 Disease denotes Covid-19 MESH:C000657245
1232 3340-3348 Disease denotes Covid-19 MESH:C000657245
1233 3634-3642 Disease denotes Covid-19 MESH:C000657245
1234 3707-3724 Disease denotes rheumatic disease MESH:D012216
1235 3729-3737 Disease denotes Covid-19 MESH:C000657245
1236 3767-3787 Disease denotes rheumatoid arthritis MESH:D001172
1237 3801-3819 Disease denotes systemic sclerosis MESH:D012595
1238 4006-4023 Disease denotes rheumatic disease MESH:D012216
1239 4137-4145 Disease denotes Covid-19 MESH:C000657245
1240 4158-4172 Disease denotes critically ill MESH:D016638
1241 4309-4329 Disease denotes rheumatoid arthritis MESH:D001172
1242 4373-4389 Disease denotes synthetic DMARDs OMIM:146820
1243 4466-4474 Disease denotes Covid-19 MESH:C000657245
1244 4700-4709 Disease denotes infection MESH:D007239
1245 4751-4768 Disease denotes rheumatic disease MESH:D012216
1246 4800-4808 Disease denotes Covid-19 MESH:C000657245
1247 4885-4913 Disease denotes systemic lupus erythematosus MESH:D008180
1248 4924-4942 Disease denotes systemic sclerosis MESH:D012595
1249 5008-5024 Disease denotes Sjogren syndrome MESH:D012859
1250 5264-5282 Disease denotes systemic sclerosis MESH:D012595
1251 5312-5320 Disease denotes Covid-19 MESH:C000657245
1252 5358-5380 Disease denotes interstitial pneumonia MESH:D009395
1253 5396-5401 Disease denotes death MESH:D003643
1254 5490-5510 Disease denotes respiratory symptoms MESH:D012818
1255 5529-5544 Disease denotes viral infection MESH:D001102
1256 5935-5953 Disease denotes rheumatic diseases MESH:D012216
1257 6010-6026 Disease denotes synthetic DMARDs OMIM:146820
1258 6124-6132 Disease denotes COVID-19 MESH:C000657245
1259 6188-6197 Disease denotes pneumonia MESH:D011014
1260 6363-6392 Disease denotes vasculitis and granulomatosis MESH:D014657
1261 6398-6410 Disease denotes polyangiitis MESH:D014890
1262 6427-6435 Disease denotes Covid-19 MESH:C000657245
1263 6436-6445 Disease denotes infection MESH:D007239
1264 6529-6537 Disease denotes Covid-19 MESH:C000657245
1265 6610-6628 Disease denotes systemic sclerosis MESH:D012595
1266 6661-6673 Disease denotes lung disease MESH:D008171
1267 6675-6678 Disease denotes ILD MESH:D017563
1268 6714-6722 Disease denotes Covid-19 MESH:C000657245
1269 6734-6743 Disease denotes pneumonia MESH:D011014
1270 6802-6820 Disease denotes systemic sclerosis MESH:D012595
1271 6889-6897 Disease denotes Covid-19 MESH:C000657245
1272 6938-6949 Disease denotes scleroderma MESH:C543759
1273 6961-6964 Disease denotes ILD MESH:D017563
1274 6969-6982 Disease denotes polyarthritis MESH:D001168
1275 7231-7239 Disease denotes Covid-19 MESH:C000657245
1276 7364-7377 Disease denotes acute disease MESH:D000208
1277 7918-7937 Disease denotes autoimmune diseases MESH:D001327
1278 7960-7968 Disease denotes Covid-19 MESH:C000657245
1279 7969-7978 Disease denotes infection MESH:D007239
1280 8061-8069 Disease denotes Covid-19 MESH:C000657245
1281 8084-8092 Disease denotes Covid-19 MESH:C000657245

2_test

Id Subject Object Predicate Lexical cue
32535093-32109013-4828883 2767-2769 32109013 denotes 90